MDMA (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "MDMA" in Greek language version.

refsWebsite

Global rank Greek rank

114nih.gov

4^th place

82doi.org

2^nd place

3^rd place

26web.archive.org

1^st place

21archive.org

6^th place

5^th place

14books.google.com

3^rd place

6^th place

8nytimes.com

7^th place

29^th place

4europa.eu

68^th place

24^th place

4unodc.org

2,494^th place

1,684^th place

4erowid.org

3,887^th place

4,036^th place

3drugabuse.gov

6,166^th place

5,180^th place

3maps.org

low place

2washingtonpost.com

34^th place

118^th place

2latimes.com

22^nd place

145^th place

2amazon.com

105^th place

426^th place

2harvard.edu

18^th place

57^th place

2espacenet.com

800^th place

4,641^st place

2isomerdesign.com

low place

2semanticscholar.org

11^th place

576^th place

2bbc.co.uk

8^th place

20^th place

1dot.gov

1,690^th place

8,386^th place

1drugs.com

399^th place

130^th place

1healthnewsreview.org

low place

1fda.gov

447^th place

368^th place

1thedea.org

low place

1unibas.ch

low place

1csp.org

low place

1medscape.com

719^th place

579^th place

1researchgate.net

120^th place

213^th place

1warwick.ac.uk

4,378^th place

8,730^th place

1worldcat.org

5^th place

8^th place

1oup.com

485^th place

574^th place

1drugbank.ca

4,294^th place

4,484^th place

1zenodo.org

621^st place

1,469^th place

1uc.pt

6,989^th place

low place

1justice.gov

918^th place

4,557^th place

1ingentaconnect.com

3,306^th place

2,260^th place

1shulginresearch.org

low place

1thedocumentarygroup.com

low place

1weeklywire.com

low place

1swansea.ac.uk

low place

1apnewsarchive.com

low place

6,538^th place

1who.int

195^th place

72^nd place

1nbcnews.com

137^th place

451^st place

1scientopia.org

low place

1vice.com

175^th place

218^th place

1statutelaw.gov.uk

low place

1aclu.org

5,482^nd place

low place

1government.nl

low place

6,027^th place

1fsijournal.org

low place

1drugtext.org

low place

1nature.com

234^th place

207^th place

1sfchronicle.com

1,400^th place

6,894^th place

1theguardian.com

12^th place

45^th place

aclu.org

Court Rejects Harsh Federal Drug Sentencing Guideline as Scientifically Unjustified | American Civil Liberties Union. Aclu.org (15 July 2011). Retrieved on 29 August 2012.

amazon.com

Molly Madness. National Geographic Channel. 13 Αυγούστου 2014. ASIN B00LIC368M.
Manic Molly. National Geographic Channel. 10 Δεκεμβρίου 2014. ASIN B00LIC368M.

apnewsarchive.com

Baker, Kathryn (30 May 1985). «DEA To Ban "Ecstasy" – The Drug MDMA». The Associated Press. http://www.apnewsarchive.com/1985/DEA-To-Ban-Ecstasy-The-Drug-MDMA/id-26214cd32a8b4c05e361158df14715b0. Ανακτήθηκε στις 7 August 2015.

archive.org

Malenka RC, Nestler EJ, Hyman SE (2009). «Chapter 15: Reinforcement and Addictive Disorders». Στο: Sydor A, Brown RY, επιμ. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd έκδοση). New York: McGraw-Hill Medical. σελίδες 375. ISBN 978-0-07-148127-4.
Freye E (28 Ιουλίου 2009). «Pharmacological Effects of MDMA in Man». Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer Netherlands. σελίδες 151–160. doi:10.1007/978-90-481-2448-0_24. ISBN 978-90-481-2448-0.
«Gender differences in the subjective effects of MDMA». Psychopharmacology 154 (2): 161–8. March 2001. doi:10.1007/s002130000648. PMID 11314678. https://archive.org/details/sim_psychopharmacology_2001-03_154_2/page/161.
«What does MDMA feel like?». Ecstasy: The complete guide. A comprehensive look at the risks and benefits of MDMA. Rochester: Park Street Press. 2001.
Freye, Enno· Levy, Joseph V. (2009). Pharmacology and abuse of cocaine, amphetamines, ecstasy and related designer drugs a comprehensive review on their mode of action, treatment of abuse and intoxication (Online-Ausg. έκδοση). Dordrecht: Springer Netherlands. σελ. 152. ISBN 978-90-481-2448-0.
«Ecstasy (MDMA) and memory function: a meta-analytic update». Human Psychopharmacology 22 (6): 381–8. August 2007. doi:10.1002/hup.857. PMID 17621368. https://archive.org/details/sim_human-psychopharmacology_2007-08_22_6/page/381.
McMillan, Beverly· Starr, Cecie (2014). Human biology (10th έκδοση). Belmont, CA: Brooks/Cole Cengage Learning. ISBN 978-1-133-59916-6.
Kellum, John A· Gunn, Scott R (2008). Oxford American Handbook of Critical Care. Oxford University Press. σελ. 464. ISBN 978-0-19-530528-9.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction 98 (3): 365–8. March 2003. doi:10.1046/j.1360-0443.2003.00292.x. PMID 12603236. https://archive.org/details/sim_british-journal-of-addiction_2003-03_98_3/page/365.
«The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs». Canadian Medical Association Journal 165 (7): 917–28. 2 October 2001. PMID 11599334. PMC 81503. https://archive.org/details/sim_canadian-medical-association-journal_2001-10-02_165_7/page/917.
«3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors». Psychopharmacology 88 (4): 525–6. 1986. doi:10.1007/BF00178519. PMID 2871581. https://archive.org/details/sim_psychopharmacology_1986-04_88_4/page/525.
«Non-linear pharmacokinetics of MDMA ('ecstasy') in humans». British Journal of Clinical Pharmacology 49 (2): 104–9. February 2000. doi:10.1046/j.1365-2125.2000.00121.x. PMID 10671903. PMC 2014905. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2000-02_49_2/page/104.
«Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans». Clinical Chemistry 45 (7): 1058–69. July 1999. doi:10.1093/clinchem/45.7.1058. PMID 10388483. https://archive.org/details/sim_clinical-chemistry_1999-07_45_7/page/1058.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International 60 (3): 189–202. August 1993. doi:10.1016/0379-0738(93)90238-6. PMID 7901132. https://archive.org/details/sim_forensic-science-international_1993-08_60_3/page/189.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Clinical Chemistry 55 (3): 454–62. March 2009. doi:10.1373/clinchem.2008.117093. PMID 19168553. PMC 2669283. https://archive.org/details/sim_clinical-chemistry_2009-03_55_3/page/454.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction 105 (8): 1355–61. August 2010. doi:10.1111/j.1360-0443.2010.02948.x. PMID 20653618. https://archive.org/details/sim_british-journal-of-addiction_2010-08_105_8/page/1355.
Shulgin, Alexander· Shulgin, Ann (1991). «Chapters 12, 22». PiHKAL : A Chemical Love Story (7th printing, 1st έκδοση). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9.
Shulgin, Ann (2004). «Tribute to Jacob». Στο: Doblin, Rick, επιμ. The Secret Chief Revealed (2nd έκδοση). Sarasota, Fl: Multidisciplinary Association for Psychedelic Studies. σελίδες 17–18. ISBN 978-0-9660019-6-9. Ανακτήθηκε στις 7 Ιανουαρίου 2015.
Beck, Jerome· Rosenbaum, Marsha (1994). «The Distribution of Ecstasy». Pursuit of Ecstasy : The MDMA Experience. Albany: State Univ. of New York Press. ISBN 978-0-7914-1817-8.
Doblin, Rick· Rosenbaum, Marsha (1991). «Chapter 6: Why MDMA Should Not Have Been Made Illegal». Στο: Inciardi, James A., επιμ. The Drug Legalization Debate (2nd έκδοση). London: Sage Publications, Inc. ISBN 978-0-8039-3678-2. Ανακτήθηκε στις 10 Αυγούστου 2015.
Holland, Julie (2001). «The History of MDMA». Στο: Holland, Julie, επιμ. Ecstasy: the complete guide; a comprehensive look at the risks and benefits of MDMA. Rochester, VT: Park Street Press. ISBN 978-0-89281-857-0.

bbc.co.uk

open.live.bbc.co.uk

Ecstasy on Prescription, BBC Business Daily, May 29, 2018.

news.bbc.co.uk

«Why ecstasy is 'vanishing' from UK nightclubs». BBC News. 19 January 2010. http://news.bbc.co.uk/1/hi/england/london/8468372.stm. Ανακτήθηκε στις 14 February 2010.

books.google.com

Palmer RB (2012). Medical toxicology of drug abuse : synthesized chemicals and psychoactive plants. Hoboken, N.J.: John Wiley & Sons. σελ. 139. ISBN 978-0-471-72760-6.
Freye, Enno (2009). Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs: A comprehensive review on their mode of action, treatment of abuse and intoxication (στα Αγγλικά). Springer Science & Business Media. σελ. 147. ISBN 978-90-481-2448-0.
Patel V (2010). Mental and neurological public health a global perspective (1st έκδοση). San Diego, CA: Academic Press/Elsevier. σελ. 57. ISBN 978-0-12-381527-9. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Σεπτεμβρίου 2017.
World Health Organization (2004). Neuroscience of Psychoactive Substance Use and Dependence. World Health Organization. σελίδες 97–. ISBN 978-92-4-156235-5.
Reynolds, Simon (1999). Generation Ecstasy: Into the World of Techno and Rave Culture. Routledge. σελ. 81. ISBN 978-0-415-92373-6.
McCrady, επιμ. (2013). Addictions: a comprehensive guidebook (Second έκδοση). Oxford: Oxford University Press. σελ. 299. ISBN 978-0-19-975366-6.
Capuzzi, David, επιμ. (21 Νοεμβρίου 2014). Youth at Risk: A Prevention Resource for Counselors, Teachers, and Parents. John Wiley & Sons. σελ. 379. ISBN 978-1-119-02694-5.
Parrott AC (2012). «13. MDMA and LSD». Στο: Verster J, Brady K, Galanter M, Conrod P, επιμ. Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. Springer Science & Business Media. σελ. 179. ISBN 978-1-4614-3375-0.
Mack, Avram H.· Brady, Kathleen T. (12 Μαΐου 2016). Clinical Textbook of Addictive Disorders. Guilford Publications. σελ. 169. ISBN 978-1-4625-2169-2. MDMA's addictive liability appears to be lower than that of other drugs of abuse....
Ries, Richard· Miller, Shannon C (2009). Principles of addiction medicine (4th έκδοση). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. σελ. 226. ISBN 978-0-7817-7477-2. MDA and MDMA are less reinforcing than amphetamine...
Mack, Avram H.· Brady, Kathleen T. (12 Μαΐου 2016). Clinical Textbook of Addictive Disorders. Guilford Publications. σελ. 171. ISBN 978-1-4625-2169-2. There are no known pharmacological treatments for MDMA addiction.
Eisner, Bruce (1994). Ecstasy : The MDMA Story (Expanded 2nd έκδοση). Berkeley, CA: Ronin Publishing. ISBN 978-0-914171-68-3.
Power, Mike (2013). Drugs 2.0 : the web revolution that's changing how the world gets high. London: Portobello. ISBN 978-1-84627-459-6.
Waldman, Ayelet (10 Ιανουαρίου 2017). A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life. Knopf Doubleday Publishing Group. ISBN 978-0-451-49410-8. Ανακτήθηκε στις 18 Μαΐου 2017.

csp.org

MDMA and Religion Αρχειοθετήθηκε 2013-04-24 στο Wayback Machine.. CSP. Retrieved on 11 June 2011.

doi.org

dx.doi.org

«Decision-making in chronic ecstasy users: a systematic review». The European Journal of Neuroscience 45 (1): 34–44. January 2017. doi:10.1111/ejn.13480. PMID 27859780. «...the addictive potential of MDMA itself is relatively small.».
«Can MDMA play a role in the treatment of substance abuse?». Current Drug Abuse Reviews 6 (1): 54–62. March 2013. doi:10.2174/18744737112059990005. PMID 23627786. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-08-03. https://web.archive.org/web/20200803194522/http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf. Ανακτήθηκε στις 2020-10-04. «Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders.».
«Toxicity of amphetamines: an update». Archives of Toxicology 86 (8): 1167–231. August 2012. doi:10.1007/s00204-012-0815-5. PMID 22392347.
«Nephrotoxic effects of designer drugs: synthetic is not better!». Nature Reviews. Nephrology 10 (6): 314–24. June 2014. doi:10.1038/nrneph.2014.44. PMID 24662435.
«3,4-methylenedioxymethamphetamine (MDMA): current perspectives». Substance Abuse and Rehabilitation 4: 83–99. 2013. doi:10.2147/SAR.S37258. PMID 24648791.
«Progress and promise for the MDMA drug development program». Psychopharmacology 235 (2): 561–571. February 2018. doi:10.1007/s00213-017-4779-2. PMID 29152674.
«FDA's Expedited Approval Mechanisms for New Drug Products». Biotechnology Law Report 34 (1): 15–37. February 2015. doi:10.1089/blr.2015.9999. PMID 25713472.
«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction 101 (9): 1241–1245. August 2006. doi:10.1111/j.1360-0443.2006.01511.x. PMID 16911722. http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.».
«Gender differences in the subjective effects of MDMA». Psychopharmacology 154 (2): 161–8. March 2001. doi:10.1007/s002130000648. PMID 11314678. https://archive.org/details/sim_psychopharmacology_2001-03_154_2/page/161.
«Review article: amphetamines and related drugs of abuse». Emergency Medicine Australasia 20 (5): 391–402. October 2008. doi:10.1111/j.1742-6723.2008.01114.x. PMID 18973636.
«Intimate insight: MDMA changes how people talk about significant others». Journal of Psychopharmacology 29 (6): 669–77. June 2015. doi:10.1177/0269881115581962. PMID 25922420.
«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology 28 (9): 847–56. September 2014. doi:10.1177/0269881114542454. PMID 25052243. http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf.
«MDMA alters emotional processing and facilitates positive social interaction». Psychopharmacology 231 (21): 4219–29. October 2014. doi:10.1007/s00213-014-3570-x. PMID 24728603.
«The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals». Neuroscience and Biobehavioral Reviews 57: 433–46. October 2015. doi:10.1016/j.neubiorev.2015.08.016. PMID 26408071.
«Making a medicine out of MDMA». The British Journal of Psychiatry 206 (1): 4–6. January 2015. doi:10.1192/bjp.bp.114.152751. PMID 25561485.
«Ecstacy: a review of MDMA and MDA». International Journal of Psychiatry in Medicine 16 (4): 359–72. 1986. doi:10.2190/dcrp-u22m-aumd-d84h. PMID 2881902.
«New age seekers: MDMA use as an adjunct to spiritual pursuit». Journal of Psychoactive Drugs 23 (3): 261–70. 1991. doi:10.1080/02791072.1991.10471587. PMID 1685513.
«Recognising and managing acute hyponatraemia». Emergency Nurse 21 (9): 32–6; quiz 37. February 2014. doi:10.7748/en2014.02.21.9.32.e1128. PMID 24494770.
«How MDMA's pharmacology and pharmacokinetics drive desired effects and harms». Journal of Clinical Pharmacology 54 (3): 245–52. March 2014. doi:10.1002/jcph.266. PMID 24431106.
«Drug use, sexual risk behaviour and sexually transmitted infections among swingers: a cross-sectional study in The Netherlands». Sexually Transmitted Infections 91 (1): 31–6. February 2015. doi:10.1136/sextrans-2014-051626. PMID 25342812. «It is known that some recreational drugs (eg, MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.».
«Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review». Current Drug Abuse Reviews 8 (1): 15–25. 2015. doi:10.2174/1874473708666150303115833. PMID 25731754.
«Neuroimaging in moderate MDMA use: A systematic review». Neuroscience and Biobehavioral Reviews 62: 21–34. March 2016. doi:10.1016/j.neubiorev.2015.12.010. PMID 26746590.
«Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine». Life Sciences 97 (1): 37–44. February 2014. doi:10.1016/j.lfs.2013.07.014. PMID 23892199. «In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex (Battaglia et al., 1987, O'Hearn et al., 1988). The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans (Seiden et al., 1988, Woolverton et al., 1989, McCann et al., 1998, Volkow et al., 2001a, McCann et al., 2005)».
«Are ecstasy induced serotonergic alterations overestimated for the majority of users?». Journal of Psychopharmacology 32 (7): 741–748. July 2018. doi:10.1177/0269881118767646. PMID 29733742. «Given the dose-response relationship between MDMA exposure and SERT reductions and the statistically non-significant SERT binding differences for users with use levels similar to the majority of real-life users, it can be speculated that SERT levels may not be significantly affected for most recreational ecstasy users.».
«Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users». Neuroscience and Biobehavioral Reviews 63: 158–67. April 2016. doi:10.1016/j.neubiorev.2016.02.003. PMID 26855234.
«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs 46 (1): 37–43. 2014. doi:10.1080/02791072.2014.873690. PMID 24830184. https://www.researchgate.net/publication/262381558.
«The harmful health effects of recreational ecstasy: a systematic review of observational evidence». Health Technology Assessment 13 (6): iii–iv, ix–xii, 1–315. January 2009. doi:10.3310/hta13050. PMID 19195429. http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf.
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE 11 (2): e0149438. 2016. doi:10.1371/journal.pone.0149438. PMID 26907605. Bibcode: 2016PLoSO..1149438K.
«Ecstasy (MDMA) and memory function: a meta-analytic update». Human Psychopharmacology 22 (6): 381–8. August 2007. doi:10.1002/hup.857. PMID 17621368. https://archive.org/details/sim_human-psychopharmacology_2007-08_22_6/page/381.
«The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation». Frontiers in Pharmacology 3: 121. 2012. doi:10.3389/fphar.2012.00121. PMID 22754527.
«Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?». British Journal of Pharmacology 161 (1): 17–32. September 2010. doi:10.1111/J.1476-5381.2010.00899.X. PMID 20718737.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet 369 (9566): 1047–53. March 2007. doi:10.1016/S0140-6736(07)60464-4. PMID 17382831 (23 March 2007).
«Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins». Drug and Chemical Toxicology 20 (4): 387–99. November 1997. doi:10.3109/01480549709003895. PMID 9433666.
«Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells». Toxicology in Vitro 24 (4): 1133–8. June 2010. doi:10.1016/j.tiv.2010.03.005. PMID 20230888. «In summary, MDMA is a moderate teratogen that could influence cardiac and neuronal differentiation in the ESC model and these results are in concordance with previous in vivo and in vitro models.».
«Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy». Neurotoxicology and Teratology 34 (3): 303–10. 2012. doi:10.1016/j.ntt.2012.02.001. PMID 22387807.
«DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation». The Journal of Neuroscience 26 (36): 9196–204. September 2006. doi:10.1523/JNEUROSCI.1124-06.2006. PMID 16957076.
«Transcriptional and epigenetic mechanisms of addiction». Nature Reviews. Neuroscience 12 (11): 623–37. October 2011. doi:10.1038/nrn3111. PMID 21989194.
«The Health Effect of Psychostimulants: A Literature Review». Pharmaceuticals 3 (7): 2333–2361. July 2010. doi:10.3390/ph3072333. PMID 27713356. «It seems to present a smaller addiction potential than cocaine or methamphetamine.».
«The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine». Biological Chemistry 392 (1–2): 103–15. January 2011. doi:10.1515/BC.2011.016. PMID 21194370. «...approximately 15% of routine MDMA users recently fit the diagnostic criteria for MDMA dependence according to the Diagnostic and Statistical Manual, fourth edition/DSMIV.».
Hysek, CM; Schmid, Y; Rickli, A; Simmler, LD; Donzelli, M; Grouzmann, E; Liechti, ME (August 2012). «Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology 166 (8): 2277–2288. doi:10.1111/j.1476-5381.2012.01936.x. ISSN 0007-1188. PMID 22404145. PMC 3448893. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448893/.
«Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators». British Journal of Pharmacology 167 (5): 946–59. November 2012. doi:10.1111/j.1476-5381.2012.02065.x. PMID 22671762.
«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia 96 (6): 678–85. June 2006. doi:10.1093/bja/ael078. PMID 16595612. https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related#4457537.
«Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition». Therapeutic Drug Monitoring 26 (2): 137–44. April 2004. doi:10.1097/00007691-200404000-00009. PMID 15228154. «It is known that some recreational drugs (e.g., MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.».
«Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition». Therapeutic Drug Monitoring 26 (2): 137–44. April 2004. doi:10.1097/00007691-200404000-00009. PMID 15228154.
«Nephrotoxic effects of common and emerging drugs of abuse». Clinical Journal of the American Society of Nephrology 9 (11): 1996–2005. November 2014. doi:10.2215/CJN.00360114. PMID 25035273.
«Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk». The Australian and New Zealand Journal of Psychiatry 41 (8): 649–55. August 2007. doi:10.1080/00048670701449237. PMID 17620161.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction 98 (3): 365–8. March 2003. doi:10.1046/j.1360-0443.2003.00292.x. PMID 12603236. https://archive.org/details/sim_british-journal-of-addiction_2003-03_98_3/page/365.
«The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity». Journal of Neurochemistry 116 (2): 164–76. January 2011. doi:10.1111/j.1471-4159.2010.07109.x. PMID 21073468.
«Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges». Pharmacology & Therapeutics 180: 161–180. December 2017. doi:10.1016/j.pharmthera.2017.07.002. PMID 28723415. «As described above, a number of psychotropic agents including amphetamine, methamphetamine, and MDMA are potent agonists at human TAAR1 (Bunzow et al., 2001; Simmler et al., 2016). The subsequently observed regulatory effect of TAAR1 on dopaminergic systems has further strengthened this interest, given their well-documented involvement in reward circuitry.».
«Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices». European Journal of Pharmacology 191 (2): 217–20. November 1990. doi:10.1016/0014-2999(90)94150-V. PMID 1982265.
«Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo». Neurochemistry International 43 (4–5): 393–400. 2003. doi:10.1016/S0197-0186(03)00027-5. PMID 12742084.
«Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites». European Journal of Pharmacology 149 (1–2): 159–63. April 1988. doi:10.1016/0014-2999(88)90056-8. PMID 2899513. https://zenodo.org/record/1253866.
«3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors». Psychopharmacology 88 (4): 525–6. 1986. doi:10.1007/BF00178519. PMID 2871581. https://archive.org/details/sim_psychopharmacology_1986-04_88_4/page/525.
«Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors». Neuroscience Letters 177 (1–2): 111–5. August 1994. doi:10.1016/0304-3940(94)90057-4. PMID 7824160.
«3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro». Molecular Pharmacology 63 (6): 1223–9. June 2003. doi:10.1124/mol.63.6.1223. PMID 12761331. https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559.
«Targeting sigma receptors: novel medication development for drug abuse and addiction». Expert Review of Clinical Pharmacology 2 (4): 351–8. July 2009. doi:10.1586/ecp.09.18. PMID 22112179.
«Non-linear pharmacokinetics of MDMA ('ecstasy') in humans». British Journal of Clinical Pharmacology 49 (2): 104–9. February 2000. doi:10.1046/j.1365-2125.2000.00121.x. PMID 10671903. PMC 2014905. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2000-02_49_2/page/104.
«Pharmacology of MDMA in humans». Annals of the New York Academy of Sciences 914 (1): 225–37. September 2000. doi:10.1111/j.1749-6632.2000.tb05199.x. PMID 11085324. Bibcode: 2000NYASA.914..225D.
«Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults». Therapeutic Drug Monitoring 30 (3): 320–32. June 2008. doi:10.1097/FTD.0b013e3181684fa0. PMID 18520604.
«Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine». Journal of Chromatography B 857 (1): 123–9. September 2007. doi:10.1016/j.jchromb.2007.07.003. PMID 17643356.
«Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans». Clinical Chemistry 45 (7): 1058–69. July 1999. doi:10.1093/clinchem/45.7.1058. PMID 10388483. https://archive.org/details/sim_clinical-chemistry_1999-07_45_7/page/1058.
«Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses». The Journal of Pharmacology and Experimental Therapeutics 327 (1): 38–44. October 2008. doi:10.1124/jpet.108.141366. PMID 18591215.
«Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors». Analytica Chimica Acta 596 (2): 231–41. July 2007. doi:10.1016/j.aca.2007.06.027. PMID 17631101.
«Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship». Chemical Research in Toxicology 19 (10): 1294–304. October 2006. doi:10.1021/tx060123i. PMID 17040098. https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf.
«A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes». Forensic Science International 155 (2–3): 141–57. December 2005. doi:10.1016/j.forsciint.2004.11.013. PMID 16226151.
«Impurity profiling of seized MDMA tablets by capillary gas chromatography». Analytical and Bioanalytical Chemistry 374 (2): 274–81. September 2002. doi:10.1007/s00216-002-1477-6. PMID 12324849.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International 60 (3): 189–202. August 1993. doi:10.1016/0379-0738(93)90238-6. PMID 7901132. https://archive.org/details/sim_forensic-science-international_1993-08_60_3/page/189.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Clinical Chemistry 55 (3): 454–62. March 2009. doi:10.1373/clinchem.2008.117093. PMID 19168553. PMC 2669283. https://archive.org/details/sim_clinical-chemistry_2009-03_55_3/page/454.
«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology 25 (2): 299–309. June 1973. doi:10.1016/S0041-008X(73)80016-X. PMID 4197635. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction 105 (8): 1355–61. August 2010. doi:10.1111/j.1360-0443.2010.02948.x. PMID 20653618. https://archive.org/details/sim_british-journal-of-addiction_2010-08_105_8/page/1355.
«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs 18 (4): 349–54. October 1986. doi:10.1080/02791072.1986.10472368. PMID 2880950. http://www.maps.org/images/pdf/1986_siegel_1.pdf.
The first confirmed sample was seized and identified by Chicago Police in 1970, see Sreenivasan VR (1972). «Problems in Identification of Methylenedioxy and Methoxy Amphetamines». Journal of Criminal Law, Criminology, and Police Science 63 (2): 304–312. doi:10.2307/1142315. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=1149.
«An exploration of the history and controversies surrounding MDMA and MDA». Journal of Psychoactive Drugs 33 (3): 213–21. 2001. doi:10.1080/02791072.2001.10400568. PMID 11718314.
«Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity». Psychopharmacology 173 (3–4): 234–41. May 2004. doi:10.1007/s00213-003-1712-7. PMID 15007594. http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf.
«MDMA on the street: Analysis Anonymous». Journal of Psychoactive Drugs 18 (4): 363–9. October 1986. doi:10.1080/02791072.1986.10472371. PMID 2880953.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence 112 (1–2): 33–8. November 2010. doi:10.1016/j.drugalcdep.2010.05.006. PMID 20570447.
«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International 223 (1–3): 298–305. November 2012. doi:10.1016/j.forsciint.2012.10.004. PMID 23107059. http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract.
«MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults». Progress in Neuro-Psychopharmacology & Biological Psychiatry 64: 237–49. January 2016. doi:10.1016/j.pnpbp.2015.03.011. PMID 25818246.
Maxmen, Amy (2017). «Psychedelic compound in ecstasy moves closer to approval to treat PTSD». Nature. doi:10.1038/nature.2017.21917. https://www.nature.com/news/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd-1.21917. Ανακτήθηκε στις 18 May 2017.
«Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA». The Lancet. Psychiatry 3 (5): 481–8. May 2016. doi:10.1016/S2215-0366(15)00576-3. PMID 27067625.
«MDMA for the treatment of mood disorder: all talk no substance?». Therapeutic Advances in Psychopharmacology 5 (3): 179–88. June 2015. doi:10.1177/2045125315583786. PMID 26199721.

doi.org

Freye E (28 Ιουλίου 2009). «Pharmacological Effects of MDMA in Man». Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer Netherlands. σελίδες 151–160. doi:10.1007/978-90-481-2448-0_24. ISBN 978-90-481-2448-0.

dot.gov

nhtsa.dot.gov

«Methylenedioxymethamphetamine (MDMA, ecstasy)». Drugs and Human Performance Fact Sheets. National Highway Traffic Safety Administration. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Μαΐου 2012.

drugabuse.gov

«DrugFacts: MDMA (Ecstasy or Molly)». National Institute on Drug Abuse. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Δεκεμβρίου 2014. Ανακτήθηκε στις 2 Δεκεμβρίου 2014.
«DrugFacts: MDMA (Ecstasy/Molly)». National Institute on Drug Abuse. Φεβρουαρίου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Μαρτίου 2016. Ανακτήθηκε στις 30 Μαρτίου 2016.
«MDMA (Ecstasy/Molly)». National Institute on Drug Abuse. Ανακτήθηκε στις 14 Ιουλίου 2018.

drugbank.ca

«Midomafetamine». Midomafetamine. University of Alberta. 2 May 2018. https://www.drugbank.ca/drugs/DB01454.

drugs.com

Anderson L, επιμ. (18 Μαΐου 2014). «MDMA». Drugs.com. Drugsite Trust. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Μαρτίου 2016. Ανακτήθηκε στις 30 Μαρτίου 2016.

drugtext.org

Drugtext – 10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do?. Drugtext.org. Retrieved on 11 June 2011. Αρχειοθετήθηκε 9 February 2012 στο Wayback Machine.

erowid.org

«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology 25 (2): 299–309. June 1973. doi:10.1016/S0041-008X(73)80016-X. PMID 4197635. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639.
The first confirmed sample was seized and identified by Chicago Police in 1970, see Sreenivasan VR (1972). «Problems in Identification of Methylenedioxy and Methoxy Amphetamines». Journal of Criminal Law, Criminology, and Police Science 63 (2): 304–312. doi:10.2307/1142315. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=1149.
Beck, Jerome E. (Απριλίου 1987). «Drug Abuse Series: MDMA». Erowid. Drug Abuse Information and Monitoring Project. Ανακτήθηκε στις 6 Αυγούστου 2015.
«MDMA – FDA REPORT, 1985». Erowid. Food and Drug Administration. 1985. Ανακτήθηκε στις 11 Αυγούστου 2015.

espacenet.com

v3.espacenet.com

Firma E. Merck in Darmstadt (16 Μαΐου 1914). «German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten». Kaiserliches Patentamt. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 12 Απριλίου 2009.
Firma E. Merck in Darmstadt (15 Οκτωβρίου 1914). «German Patent 279194: Verfahren zur Darstellung von Hydrastinin Derivaten». Kaiserliches Patentamt. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 4 Οκτωβρίου 2020.

europa.eu

emcdda.europa.eu

«Methylenedioxymethamphetamine (MDMA or 'Ecstasy')». EMCDDA. European Monitoring Centre for Drugs and Drug Addiction. Ανακτήθηκε στις 17 Οκτωβρίου 2014.
«Statistical Bulletin 2018 — prevalence of drug use | www.emcdda.europa.eu». www.emcdda.europa.eu. Ανακτήθηκε στις 5 Φεβρουαρίου 2019.
European Monitoring Centre for Drugs and Drug Addiction (2008). Annual report: the state of the drugs problem in Europe (PDF). Luxembourg: Office for Official Publications of the European Communities. σελ. 49. ISBN 978-92-9168-324-6. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Απριλίου 2013. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
«European Drug Report 2014, page 26» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 7 Σεπτεμβρίου 2014. Ανακτήθηκε στις 4 Οκτωβρίου 2020.

fda.gov

«Fact Sheet: Breakthrough Therapies». United States Food and Drug Administration. 10 Δεκεμβρίου 2014. Αρχειοθετήθηκε από το πρωτότυπο στις 9 Οκτωβρίου 2017. Ανακτήθηκε στις 9 Οκτωβρίου 2017. A breakthrough therapy is a drug:
Πρότυπο:Bullintended alone or in combination with one or more other drugs to treat a serious or life-threatening disease or condition and
Πρότυπο:Bullpreliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.

fsijournal.org

«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International 223 (1–3): 298–305. November 2012. doi:10.1016/j.forsciint.2012.10.004. PMID 23107059. http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract.

government.nl

«Committee: the current system of the Opium Act does not have to be changed». government.nl. 24 Ιουνίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Απριλίου 2012. Ανακτήθηκε στις 29 Αυγούστου 2012.

harvard.edu

adsabs.harvard.edu

«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE 11 (2): e0149438. 2016. doi:10.1371/journal.pone.0149438. PMID 26907605. Bibcode: 2016PLoSO..1149438K.
«Pharmacology of MDMA in humans». Annals of the New York Academy of Sciences 914 (1): 225–37. September 2000. doi:10.1111/j.1749-6632.2000.tb05199.x. PMID 11085324. Bibcode: 2000NYASA.914..225D.

healthnewsreview.org

«CBS proclaims 'cancer breakthrough' – doesn't explain what FDA means by that term». Health News Review. 13 May 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-12-08. https://web.archive.org/web/20201208215931/https://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/. Ανακτήθηκε στις 9 October 2017.

ingentaconnect.com

«The origin of MDMA ("ecstasy")--separating the facts from the myth». Die Pharmazie 61 (11): 966–72. November 2006. PMID 17152992. http://www.ingentaconnect.com/content/govi/pharmaz/2006/00000061/00000011/art00015.

isomerdesign.com

«Schedule I». Controlled Drugs and Substances Act. Isomer Design. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013. Ανακτήθηκε στις 9 Δεκεμβρίου 2013.
«Definitions and interpretations». Controlled Drugs and Substances Act. Isomer Design. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013. Ανακτήθηκε στις 9 Δεκεμβρίου 2013.

justice.gov

Nov 2005 DEA Microgram newsletter, p. 166 Αρχειοθετήθηκε 18 October 2012 στο Wayback Machine.. Usdoj.gov (11 November 2005). Retrieved on 12 August 2013.

latimes.com

articles.latimes.com

Zarembo, Alan (15 March 2014). «Exploring therapeutic effects of MDMA on post-traumatic stress». Los Angeles Times (Los Angeles Times). https://articles.latimes.com/2014/mar/15/local/la-me-mdma-20140316/1. Ανακτήθηκε στις 22 February 2015. ^{[νεκρός σύνδεσμος]}
Corwin, Miles (31 May 1985). «U.S. to Ban Use of Drug MDMA : Street Abuse Cited; Used by Psychiatrists». Los Angeles Times. https://articles.latimes.com/1985-05-31/news/mn-14566_1_street-drugs. Ανακτήθηκε στις 11 August 2015.

maps.org

«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs 18 (4): 349–54. October 1986. doi:10.1080/02791072.1986.10472368. PMID 2880950. http://www.maps.org/images/pdf/1986_siegel_1.pdf.
«Schedules of Controlled Substances Proposed Placement of 3,4-Methylenedioxymethamphetamine in Schedule I». Federal Register 49 (146): 30210. 27 July 1984. http://maps.org/research-archive/dea-mdma/pdf/0194.PDF. Ανακτήθηκε στις 15 January 2015.
Adler, Jerry; Abramson, Pamela; Katz, Susan; Hager, Mary (15 April 1985). «Getting High on 'Ecstasy'». Newsweek Magazine (Life/Style): σελ. 96. http://www.maps.org/research-archive/hmma/Newsweek4.85.pdf. Ανακτήθηκε στις 1 February 2015.

medscape.com

emedicine.medscape.com

Hahn I (25 Μαρτίου 2015). «MDMA Toxicity: Background, Pathophysiology, Epidemiology». Medscape. Ανακτήθηκε στις 14 Μαΐου 2016.

nature.com

Maxmen, Amy (2017). «Psychedelic compound in ecstasy moves closer to approval to treat PTSD». Nature. doi:10.1038/nature.2017.21917. https://www.nature.com/news/psychedelic-compound-in-ecstasy-moves-closer-to-approval-to-treat-ptsd-1.21917. Ανακτήθηκε στις 18 May 2017.

nbcnews.com

James, Susan Donaldson (23 Φεβρουαρίου 2015). «What Is Molly and Why Is It Dangerous?». NBCNews.com. Ανακτήθηκε στις 23 Φεβρουαρίου 2015. Why is it called Molly? That's short for "molecule." "You can put a ribbon and bow on it and call it a cute name like 'Molly' and people are all in," said Paul Doering, professor emeritus of pharmacology at the University of Florida.

nih.gov

ncbi.nlm.nih.gov

«Decision-making in chronic ecstasy users: a systematic review». The European Journal of Neuroscience 45 (1): 34–44. January 2017. doi:10.1111/ejn.13480. PMID 27859780. «...the addictive potential of MDMA itself is relatively small.».
«Can MDMA play a role in the treatment of substance abuse?». Current Drug Abuse Reviews 6 (1): 54–62. March 2013. doi:10.2174/18744737112059990005. PMID 23627786. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-08-03. https://web.archive.org/web/20200803194522/http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf. Ανακτήθηκε στις 2020-10-04. «Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders.».
«Toxicity of amphetamines: an update». Archives of Toxicology 86 (8): 1167–231. August 2012. doi:10.1007/s00204-012-0815-5. PMID 22392347.
«Nephrotoxic effects of designer drugs: synthetic is not better!». Nature Reviews. Nephrology 10 (6): 314–24. June 2014. doi:10.1038/nrneph.2014.44. PMID 24662435.
«3,4-methylenedioxymethamphetamine (MDMA): current perspectives». Substance Abuse and Rehabilitation 4: 83–99. 2013. doi:10.2147/SAR.S37258. PMID 24648791.
«Progress and promise for the MDMA drug development program». Psychopharmacology 235 (2): 561–571. February 2018. doi:10.1007/s00213-017-4779-2. PMID 29152674.
«FDA's Expedited Approval Mechanisms for New Drug Products». Biotechnology Law Report 34 (1): 15–37. February 2015. doi:10.1089/blr.2015.9999. PMID 25713472.
«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction 101 (9): 1241–1245. August 2006. doi:10.1111/j.1360-0443.2006.01511.x. PMID 16911722. http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.».
«Gender differences in the subjective effects of MDMA». Psychopharmacology 154 (2): 161–8. March 2001. doi:10.1007/s002130000648. PMID 11314678. https://archive.org/details/sim_psychopharmacology_2001-03_154_2/page/161.
«Review article: amphetamines and related drugs of abuse». Emergency Medicine Australasia 20 (5): 391–402. October 2008. doi:10.1111/j.1742-6723.2008.01114.x. PMID 18973636.
«Intimate insight: MDMA changes how people talk about significant others». Journal of Psychopharmacology 29 (6): 669–77. June 2015. doi:10.1177/0269881115581962. PMID 25922420.
«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology 28 (9): 847–56. September 2014. doi:10.1177/0269881114542454. PMID 25052243. http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf.
«MDMA alters emotional processing and facilitates positive social interaction». Psychopharmacology 231 (21): 4219–29. October 2014. doi:10.1007/s00213-014-3570-x. PMID 24728603.
«The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals». Neuroscience and Biobehavioral Reviews 57: 433–46. October 2015. doi:10.1016/j.neubiorev.2015.08.016. PMID 26408071.
«Making a medicine out of MDMA». The British Journal of Psychiatry 206 (1): 4–6. January 2015. doi:10.1192/bjp.bp.114.152751. PMID 25561485.
«Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice». Innovations in Clinical Neuroscience 14 (1–2): 40–52. 1 February 2017. PMID 28386520. «MDMA is listed as a Schedule 1 drug by the United States Drug Enforcement Agency, meaning that currently there are no accepted medical uses for MDMA in the United States, there is a lack of accepted safety for use under medical supervision, and there is a high potential for abuse.».
«Ecstacy: a review of MDMA and MDA». International Journal of Psychiatry in Medicine 16 (4): 359–72. 1986. doi:10.2190/dcrp-u22m-aumd-d84h. PMID 2881902.
«New age seekers: MDMA use as an adjunct to spiritual pursuit». Journal of Psychoactive Drugs 23 (3): 261–70. 1991. doi:10.1080/02791072.1991.10471587. PMID 1685513.
«Recognising and managing acute hyponatraemia». Emergency Nurse 21 (9): 32–6; quiz 37. February 2014. doi:10.7748/en2014.02.21.9.32.e1128. PMID 24494770.
«How MDMA's pharmacology and pharmacokinetics drive desired effects and harms». Journal of Clinical Pharmacology 54 (3): 245–52. March 2014. doi:10.1002/jcph.266. PMID 24431106.
«Drug use, sexual risk behaviour and sexually transmitted infections among swingers: a cross-sectional study in The Netherlands». Sexually Transmitted Infections 91 (1): 31–6. February 2015. doi:10.1136/sextrans-2014-051626. PMID 25342812. «It is known that some recreational drugs (eg, MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.».
«Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review». Current Drug Abuse Reviews 8 (1): 15–25. 2015. doi:10.2174/1874473708666150303115833. PMID 25731754.
«Neuroimaging in moderate MDMA use: A systematic review». Neuroscience and Biobehavioral Reviews 62: 21–34. March 2016. doi:10.1016/j.neubiorev.2015.12.010. PMID 26746590.
«Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines». Dialogues in Clinical Neuroscience 11 (3): 305–17. 2009. PMID 19877498.
«Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine». Life Sciences 97 (1): 37–44. February 2014. doi:10.1016/j.lfs.2013.07.014. PMID 23892199. «In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex (Battaglia et al., 1987, O'Hearn et al., 1988). The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans (Seiden et al., 1988, Woolverton et al., 1989, McCann et al., 1998, Volkow et al., 2001a, McCann et al., 2005)».
«Are ecstasy induced serotonergic alterations overestimated for the majority of users?». Journal of Psychopharmacology 32 (7): 741–748. July 2018. doi:10.1177/0269881118767646. PMID 29733742. «Given the dose-response relationship between MDMA exposure and SERT reductions and the statistically non-significant SERT binding differences for users with use levels similar to the majority of real-life users, it can be speculated that SERT levels may not be significantly affected for most recreational ecstasy users.».
«Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users». Neuroscience and Biobehavioral Reviews 63: 158–67. April 2016. doi:10.1016/j.neubiorev.2016.02.003. PMID 26855234.
«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs 46 (1): 37–43. 2014. doi:10.1080/02791072.2014.873690. PMID 24830184. https://www.researchgate.net/publication/262381558.
«The harmful health effects of recreational ecstasy: a systematic review of observational evidence». Health Technology Assessment 13 (6): iii–iv, ix–xii, 1–315. January 2009. doi:10.3310/hta13050. PMID 19195429. http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf.
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE 11 (2): e0149438. 2016. doi:10.1371/journal.pone.0149438. PMID 26907605. Bibcode: 2016PLoSO..1149438K.
«Ecstasy (MDMA) and memory function: a meta-analytic update». Human Psychopharmacology 22 (6): 381–8. August 2007. doi:10.1002/hup.857. PMID 17621368. https://archive.org/details/sim_human-psychopharmacology_2007-08_22_6/page/381.
«The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation». Frontiers in Pharmacology 3: 121. 2012. doi:10.3389/fphar.2012.00121. PMID 22754527.
«Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?». British Journal of Pharmacology 161 (1): 17–32. September 2010. doi:10.1111/J.1476-5381.2010.00899.X. PMID 20718737.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet 369 (9566): 1047–53. March 2007. doi:10.1016/S0140-6736(07)60464-4. PMID 17382831 (23 March 2007).
«Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins». Drug and Chemical Toxicology 20 (4): 387–99. November 1997. doi:10.3109/01480549709003895. PMID 9433666.
«Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells». Toxicology in Vitro 24 (4): 1133–8. June 2010. doi:10.1016/j.tiv.2010.03.005. PMID 20230888. «In summary, MDMA is a moderate teratogen that could influence cardiac and neuronal differentiation in the ESC model and these results are in concordance with previous in vivo and in vitro models.».
«Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy». Neurotoxicology and Teratology 34 (3): 303–10. 2012. doi:10.1016/j.ntt.2012.02.001. PMID 22387807.
«DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation». The Journal of Neuroscience 26 (36): 9196–204. September 2006. doi:10.1523/JNEUROSCI.1124-06.2006. PMID 16957076.
«Transcriptional and epigenetic mechanisms of addiction». Nature Reviews. Neuroscience 12 (11): 623–37. October 2011. doi:10.1038/nrn3111. PMID 21989194.
«The Health Effect of Psychostimulants: A Literature Review». Pharmaceuticals 3 (7): 2333–2361. July 2010. doi:10.3390/ph3072333. PMID 27713356. «It seems to present a smaller addiction potential than cocaine or methamphetamine.».
«The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine». Biological Chemistry 392 (1–2): 103–15. January 2011. doi:10.1515/BC.2011.016. PMID 21194370. «...approximately 15% of routine MDMA users recently fit the diagnostic criteria for MDMA dependence according to the Diagnostic and Statistical Manual, fourth edition/DSMIV.».
Hysek, CM; Schmid, Y; Rickli, A; Simmler, LD; Donzelli, M; Grouzmann, E; Liechti, ME (August 2012). «Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology 166 (8): 2277–2288. doi:10.1111/j.1476-5381.2012.01936.x. ISSN 0007-1188. PMID 22404145. PMC 3448893. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448893/.
«Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators». British Journal of Pharmacology 167 (5): 946–59. November 2012. doi:10.1111/j.1476-5381.2012.02065.x. PMID 22671762.
«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia 96 (6): 678–85. June 2006. doi:10.1093/bja/ael078. PMID 16595612. https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related#4457537.
«Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition». Therapeutic Drug Monitoring 26 (2): 137–44. April 2004. doi:10.1097/00007691-200404000-00009. PMID 15228154. «It is known that some recreational drugs (e.g., MDMA or GHB) may hamper the potential to ejaculate or maintain an erection.».
«Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition». Therapeutic Drug Monitoring 26 (2): 137–44. April 2004. doi:10.1097/00007691-200404000-00009. PMID 15228154.
«3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition». British Journal of Nursing 19 (2): 94–100. 2010. PMID 20235382.
«Nephrotoxic effects of common and emerging drugs of abuse». Clinical Journal of the American Society of Nephrology 9 (11): 1996–2005. November 2014. doi:10.2215/CJN.00360114. PMID 25035273.
«Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk». The Australian and New Zealand Journal of Psychiatry 41 (8): 649–55. August 2007. doi:10.1080/00048670701449237. PMID 17620161.
«Death following ingestion of MDMA (ecstasy) and moclobemide». Addiction 98 (3): 365–8. March 2003. doi:10.1046/j.1360-0443.2003.00292.x. PMID 12603236. https://archive.org/details/sim_british-journal-of-addiction_2003-03_98_3/page/365.
«The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity». Journal of Neurochemistry 116 (2): 164–76. January 2011. doi:10.1111/j.1471-4159.2010.07109.x. PMID 21073468.
«Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges». Pharmacology & Therapeutics 180: 161–180. December 2017. doi:10.1016/j.pharmthera.2017.07.002. PMID 28723415. «As described above, a number of psychotropic agents including amphetamine, methamphetamine, and MDMA are potent agonists at human TAAR1 (Bunzow et al., 2001; Simmler et al., 2016). The subsequently observed regulatory effect of TAAR1 on dopaminergic systems has further strengthened this interest, given their well-documented involvement in reward circuitry.».
«Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices». European Journal of Pharmacology 191 (2): 217–20. November 1990. doi:10.1016/0014-2999(90)94150-V. PMID 1982265.
«Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo». Neurochemistry International 43 (4–5): 393–400. 2003. doi:10.1016/S0197-0186(03)00027-5. PMID 12742084.
«The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs». Canadian Medical Association Journal 165 (7): 917–28. 2 October 2001. PMID 11599334. PMC 81503. https://archive.org/details/sim_canadian-medical-association-journal_2001-10-02_165_7/page/917.
«Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites». European Journal of Pharmacology 149 (1–2): 159–63. April 1988. doi:10.1016/0014-2999(88)90056-8. PMID 2899513. https://zenodo.org/record/1253866.
«3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors». Psychopharmacology 88 (4): 525–6. 1986. doi:10.1007/BF00178519. PMID 2871581. https://archive.org/details/sim_psychopharmacology_1986-04_88_4/page/525.
«Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors». Neuroscience Letters 177 (1–2): 111–5. August 1994. doi:10.1016/0304-3940(94)90057-4. PMID 7824160.
«3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro». Molecular Pharmacology 63 (6): 1223–9. June 2003. doi:10.1124/mol.63.6.1223. PMID 12761331. https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559.
«Targeting sigma receptors: novel medication development for drug abuse and addiction». Expert Review of Clinical Pharmacology 2 (4): 351–8. July 2009. doi:10.1586/ecp.09.18. PMID 22112179.
«Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans». The Journal of Pharmacology and Experimental Therapeutics 290 (1): 136–45. July 1999. PMID 10381769.
«Non-linear pharmacokinetics of MDMA ('ecstasy') in humans». British Journal of Clinical Pharmacology 49 (2): 104–9. February 2000. doi:10.1046/j.1365-2125.2000.00121.x. PMID 10671903. PMC 2014905. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2000-02_49_2/page/104.
«Pharmacology of MDMA in humans». Annals of the New York Academy of Sciences 914 (1): 225–37. September 2000. doi:10.1111/j.1749-6632.2000.tb05199.x. PMID 11085324. Bibcode: 2000NYASA.914..225D.
«Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults». Therapeutic Drug Monitoring 30 (3): 320–32. June 2008. doi:10.1097/FTD.0b013e3181684fa0. PMID 18520604.
«Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine». Journal of Chromatography B 857 (1): 123–9. September 2007. doi:10.1016/j.jchromb.2007.07.003. PMID 17643356.
«Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans». Clinical Chemistry 45 (7): 1058–69. July 1999. doi:10.1093/clinchem/45.7.1058. PMID 10388483. https://archive.org/details/sim_clinical-chemistry_1999-07_45_7/page/1058.
«Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses». The Journal of Pharmacology and Experimental Therapeutics 327 (1): 38–44. October 2008. doi:10.1124/jpet.108.141366. PMID 18591215.
«Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors». Analytica Chimica Acta 596 (2): 231–41. July 2007. doi:10.1016/j.aca.2007.06.027. PMID 17631101.
«Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship». Chemical Research in Toxicology 19 (10): 1294–304. October 2006. doi:10.1021/tx060123i. PMID 17040098. https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf.
«A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes». Forensic Science International 155 (2–3): 141–57. December 2005. doi:10.1016/j.forsciint.2004.11.013. PMID 16226151.
«Impurity profiling of seized MDMA tablets by capillary gas chromatography». Analytical and Bioanalytical Chemistry 374 (2): 274–81. September 2002. doi:10.1007/s00216-002-1477-6. PMID 12324849.
«A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis». Forensic Science International 60 (3): 189–202. August 1993. doi:10.1016/0379-0738(93)90238-6. PMID 7901132. https://archive.org/details/sim_forensic-science-international_1993-08_60_3/page/189.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Clinical Chemistry 55 (3): 454–62. March 2009. doi:10.1373/clinchem.2008.117093. PMID 19168553. PMC 2669283. https://archive.org/details/sim_clinical-chemistry_2009-03_55_3/page/454.
«The origin of MDMA ("ecstasy")--separating the facts from the myth». Die Pharmazie 61 (11): 966–72. November 2006. PMID 17152992. http://www.ingentaconnect.com/content/govi/pharmaz/2006/00000061/00000011/art00015.
«Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals». Toxicology and Applied Pharmacology 25 (2): 299–309. June 1973. doi:10.1016/S0041-008X(73)80016-X. PMID 4197635. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=639.
«Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin». Addiction 105 (8): 1355–61. August 2010. doi:10.1111/j.1360-0443.2010.02948.x. PMID 20653618. https://archive.org/details/sim_british-journal-of-addiction_2010-08_105_8/page/1355.
«MDMA. Nonmedical use and intoxication». Journal of Psychoactive Drugs 18 (4): 349–54. October 1986. doi:10.1080/02791072.1986.10472368. PMID 2880950. http://www.maps.org/images/pdf/1986_siegel_1.pdf.
«An exploration of the history and controversies surrounding MDMA and MDA». Journal of Psychoactive Drugs 33 (3): 213–21. 2001. doi:10.1080/02791072.2001.10400568. PMID 11718314.
«Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity». Psychopharmacology 173 (3–4): 234–41. May 2004. doi:10.1007/s00213-003-1712-7. PMID 15007594. http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf.
«MDMA on the street: Analysis Anonymous». Journal of Psychoactive Drugs 18 (4): 363–9. October 1986. doi:10.1080/02791072.1986.10472371. PMID 2880953.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence 112 (1–2): 33–8. November 2010. doi:10.1016/j.drugalcdep.2010.05.006. PMID 20570447.
«Monitoring of illicit pill distribution networks using an image collection exploration framework». Forensic Science International 223 (1–3): 298–305. November 2012. doi:10.1016/j.forsciint.2012.10.004. PMID 23107059. http://www.fsijournal.org/article/S0379-0738(12)00458-6/abstract.
«MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults». Progress in Neuro-Psychopharmacology & Biological Psychiatry 64: 237–49. January 2016. doi:10.1016/j.pnpbp.2015.03.011. PMID 25818246.
«Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA». The Lancet. Psychiatry 3 (5): 481–8. May 2016. doi:10.1016/S2215-0366(15)00576-3. PMID 27067625.
«MDMA for the treatment of mood disorder: all talk no substance?». Therapeutic Advances in Psychopharmacology 5 (3): 179–88. June 2015. doi:10.1177/2045125315583786. PMID 26199721.

pubmedcentral.nih.gov

«3,4-methylenedioxymethamphetamine (MDMA): current perspectives». Substance Abuse and Rehabilitation 4: 83–99. 2013. doi:10.2147/SAR.S37258. PMID 24648791.
«FDA's Expedited Approval Mechanisms for New Drug Products». Biotechnology Law Report 34 (1): 15–37. February 2015. doi:10.1089/blr.2015.9999. PMID 25713472.
«Intimate insight: MDMA changes how people talk about significant others». Journal of Psychopharmacology 29 (6): 669–77. June 2015. doi:10.1177/0269881115581962. PMID 25922420.
«MDMA alters emotional processing and facilitates positive social interaction». Psychopharmacology 231 (21): 4219–29. October 2014. doi:10.1007/s00213-014-3570-x. PMID 24728603.
«The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals». Neuroscience and Biobehavioral Reviews 57: 433–46. October 2015. doi:10.1016/j.neubiorev.2015.08.016. PMID 26408071.
«Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice». Innovations in Clinical Neuroscience 14 (1–2): 40–52. 1 February 2017. PMID 28386520. «MDMA is listed as a Schedule 1 drug by the United States Drug Enforcement Agency, meaning that currently there are no accepted medical uses for MDMA in the United States, there is a lack of accepted safety for use under medical supervision, and there is a high potential for abuse.».
«Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines». Dialogues in Clinical Neuroscience 11 (3): 305–17. 2009. PMID 19877498.
«Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine». Life Sciences 97 (1): 37–44. February 2014. doi:10.1016/j.lfs.2013.07.014. PMID 23892199. «In contrast, MDMA produces damage to serotonergic, but not dopaminergic axon terminals in the striatum, hippocampus, and prefrontal cortex (Battaglia et al., 1987, O'Hearn et al., 1988). The damage associated with Meth and MDMA has been shown to persist for at least 2 years in rodents, non-human primates and humans (Seiden et al., 1988, Woolverton et al., 1989, McCann et al., 1998, Volkow et al., 2001a, McCann et al., 2005)».
«Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective». PLOS ONE 11 (2): e0149438. 2016. doi:10.1371/journal.pone.0149438. PMID 26907605. Bibcode: 2016PLoSO..1149438K.
«The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation». Frontiers in Pharmacology 3: 121. 2012. doi:10.3389/fphar.2012.00121. PMID 22754527.
«Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?». British Journal of Pharmacology 161 (1): 17–32. September 2010. doi:10.1111/J.1476-5381.2010.00899.X. PMID 20718737.
«Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy». Neurotoxicology and Teratology 34 (3): 303–10. 2012. doi:10.1016/j.ntt.2012.02.001. PMID 22387807.
«DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation». The Journal of Neuroscience 26 (36): 9196–204. September 2006. doi:10.1523/JNEUROSCI.1124-06.2006. PMID 16957076.
«Transcriptional and epigenetic mechanisms of addiction». Nature Reviews. Neuroscience 12 (11): 623–37. October 2011. doi:10.1038/nrn3111. PMID 21989194.
«The Health Effect of Psychostimulants: A Literature Review». Pharmaceuticals 3 (7): 2333–2361. July 2010. doi:10.3390/ph3072333. PMID 27713356. «It seems to present a smaller addiction potential than cocaine or methamphetamine.».
«The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine». Biological Chemistry 392 (1–2): 103–15. January 2011. doi:10.1515/BC.2011.016. PMID 21194370. «...approximately 15% of routine MDMA users recently fit the diagnostic criteria for MDMA dependence according to the Diagnostic and Statistical Manual, fourth edition/DSMIV.».
Hysek, CM; Schmid, Y; Rickli, A; Simmler, LD; Donzelli, M; Grouzmann, E; Liechti, ME (August 2012). «Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology 166 (8): 2277–2288. doi:10.1111/j.1476-5381.2012.01936.x. ISSN 0007-1188. PMID 22404145. PMC 3448893. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448893/.
«Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators». British Journal of Pharmacology 167 (5): 946–59. November 2012. doi:10.1111/j.1476-5381.2012.02065.x. PMID 22671762.
«Nephrotoxic effects of common and emerging drugs of abuse». Clinical Journal of the American Society of Nephrology 9 (11): 1996–2005. November 2014. doi:10.2215/CJN.00360114. PMID 25035273.
«The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity». Journal of Neurochemistry 116 (2): 164–76. January 2011. doi:10.1111/j.1471-4159.2010.07109.x. PMID 21073468.
«The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs». Canadian Medical Association Journal 165 (7): 917–28. 2 October 2001. PMID 11599334. PMC 81503. https://archive.org/details/sim_canadian-medical-association-journal_2001-10-02_165_7/page/917.
«Targeting sigma receptors: novel medication development for drug abuse and addiction». Expert Review of Clinical Pharmacology 2 (4): 351–8. July 2009. doi:10.1586/ecp.09.18. PMID 22112179.
«Non-linear pharmacokinetics of MDMA ('ecstasy') in humans». British Journal of Clinical Pharmacology 49 (2): 104–9. February 2000. doi:10.1046/j.1365-2125.2000.00121.x. PMID 10671903. PMC 2014905. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2000-02_49_2/page/104.
«Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults». Therapeutic Drug Monitoring 30 (3): 320–32. June 2008. doi:10.1097/FTD.0b013e3181684fa0. PMID 18520604.
«Disposition of MDMA and metabolites in human sweat following controlled MDMA administration». Clinical Chemistry 55 (3): 454–62. March 2009. doi:10.1373/clinchem.2008.117093. PMID 19168553. PMC 2669283. https://archive.org/details/sim_clinical-chemistry_2009-03_55_3/page/454.
«Ecstasy use among US adolescents from 1999 to 2008». Drug and Alcohol Dependence 112 (1–2): 33–8. November 2010. doi:10.1016/j.drugalcdep.2010.05.006. PMID 20570447.
«MDMA for the treatment of mood disorder: all talk no substance?». Therapeutic Advances in Psychopharmacology 5 (3): 179–88. June 2015. doi:10.1177/2045125315583786. PMID 26199721.

toxnet.nlm.nih.gov

«3,4-Methylenedioxymethamphetamine». Hazardous Substances Data Bank. National Library of Medicine. 28 Αυγούστου 2008. Ανακτήθηκε στις 22 Αυγούστου 2014.
«3,4-Methylenedioxymethamphetamine». Hazardous Substances Data Bank. National Library of Medicine. 28 Αυγούστου 2008. Ανακτήθηκε στις 22 Αυγούστου 2014.

nytimes.com

Philipps, Dave (1 May 2018). «Ecstasy as a Remedy for PTSD? You Probably Have Some Questions.» (στα αγγλικά). The New York Times. https://www.nytimes.com/2018/05/01/us/ecstasy-molly-ptsd-mdma.html. Ανακτήθηκε στις 14 July 2018.
Foderaro, Lisa W. (11 December 1988). «Psychedelic Drug Called Ecstasy Gains Popularity in Manhattan Nightclubs». The New York Times (The New York Times Company). https://www.nytimes.com/1988/12/11/nyregion/psychedelic-drug-called-ecstasy-gains-popularity-in-manhattan-nightclubs.html?pagewanted=2. Ανακτήθηκε στις 27 August 2015.
Bennett, Drake (30 January 2005). «Dr. Ecstasy.». New York Times Magazine. https://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html.
«U.S. will ban 'ecstasy,' a hallucinogenic drug». The New York Times. The Associated Press. 1 June 1985. https://www.nytimes.com/1985/06/01/us/us-will-ban-ecstasy-a-hallucinogenic-drug.html. Ανακτήθηκε στις 29 April 2015.
Weber, Bruce (7 June 2014). «Alexander Shulgin, Psychedelia Researcher, Dies at 88». The New York Times (The New York Times Company). https://www.nytimes.com/2014/06/08/us/alexander-shulgin-psychedelia-researcher-dies-at-88.html?_r=0. Ανακτήθηκε στις 28 August 2015.
Aleksander, Irina (21 June 2013). «Molly: Pure, but Not So Simple». The New York Times (The New York Times Company). https://www.nytimes.com/2013/06/23/fashion/molly-pure-but-not-so-simple.html. Ανακτήθηκε στις 24 February 2015.
Philipps, Dave (29 November 2016). «F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients». The New York Times. The New York Times Company. Αρχειοθετήθηκε από το πρωτότυπο στις 6 January 2017. https://web.archive.org/web/20170106084750/http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html. Ανακτήθηκε στις 1 December 2016.

artsbeat.blogs.nytimes.com

McKinley, James C. (12 September 2013). «Overdoses of 'Molly' Led to Electric Zoo Deaths». The New York Times. http://artsbeat.blogs.nytimes.com/2013/09/12/overdoses-of-molly-led-to-electric-zoo-deaths/?_r=0. Ανακτήθηκε στις 9 December 2013.

oup.com

academic.oup.com

«Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management». British Journal of Anaesthesia 96 (6): 678–85. June 2006. doi:10.1093/bja/ael078. PMID 16595612. https://academic.oup.com/bja/article/96/6/678/326917/Acute-toxic-effects-of-Ecstasy-MDMA-and-related#4457537.

researchgate.net

«The potential dangers of using MDMA for psychotherapy». Journal of Psychoactive Drugs 46 (1): 37–43. 2014. doi:10.1080/02791072.2014.873690. PMID 24830184. https://www.researchgate.net/publication/262381558.

scientopia.org

«Mephedrone (4-Methylmethcathinone) appearing in "Ecstasy" in the Netherlands». 19 September 2010. Αρχειοθετήθηκε από το πρωτότυπο στις 2012-11-05. https://web.archive.org/web/20121105125943/http://scientopia.org/blogs/drugmonkey/2010/09/19/mephedrone-4-methylmethcathinone-appearing-in-ecstasy-in-the-netherlands/. Ανακτήθηκε στις 31 December 2012.

semanticscholar.org

pdfs.semanticscholar.org

«Can MDMA play a role in the treatment of substance abuse?». Current Drug Abuse Reviews 6 (1): 54–62. March 2013. doi:10.2174/18744737112059990005. PMID 23627786. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-08-03. https://web.archive.org/web/20200803194522/http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf. Ανακτήθηκε στις 2020-10-04. «Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders.».

semanticscholar.org

«3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro». Molecular Pharmacology 63 (6): 1223–9. June 2003. doi:10.1124/mol.63.6.1223. PMID 12761331. https://semanticscholar.org/paper/cca65f5f2be82316522d7a1ceb315764b75dd559.

sfchronicle.com

Lattin, Don (19 Μαρτίου 2015). «Patients in ecstasy clinical trial find drug beneficial». San Francisco Chronicle. Hearst Corporation. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Απριλίου 2016. Ανακτήθηκε στις 28 Απριλίου 2016.

shulginresearch.org

«Alexander 'Sasha' Shulgin». Alexander Shulgin Research Institute. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Δεκεμβρίου 2014. Ανακτήθηκε στις 8 Ιανουαρίου 2015.

statutelaw.gov.uk

Misuse of Drugs Act 1971. Statutelaw.gov.uk (5 January 1998). Retrieved on 11 June 2011.

swansea.ac.uk

psy.swansea.ac.uk

«Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity». Psychopharmacology 173 (3–4): 234–41. May 2004. doi:10.1007/s00213-003-1712-7. PMID 15007594. http://psy.swansea.ac.uk/staff/parrott/p-IsEcstasyMDMA-Psychopharm-2004.pdf.

thedea.org

«The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents». Addiction 101 (9): 1241–1245. August 2006. doi:10.1111/j.1360-0443.2006.01511.x. PMID 16911722. http://www.thedea.org/docs/2006_Freudenmann_22846_1.pdf. «Although MDMA was, in fact, first synthesized at Merck in 1912, it was not tested pharmacologically because it was only an unimportant precursor in a new synthesis for haemostatic substances.».

thedocumentarygroup.com

Jennings, Peter (1 April 2004). «Ecstasy Rising». Primetime Thursday (ABC News) (Special edition). Αρχειοθετήθηκε από το πρωτότυπο στις 27 May 2015. https://web.archive.org/web/20150527163756/http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc.

theguardian.com

Devlin, Hannah (30 June 2017). «World's first trials of MDMA to treat alcohol addiction set to begin». The Guardian. https://www.theguardian.com/science/2017/jun/30/world-first-trials-mdma-treat-alcohol-addiction-set-begin?CMP=fb_gu.

uc.pt

estudogeral.sib.uc.pt

«Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship». Chemical Research in Toxicology 19 (10): 1294–304. October 2006. doi:10.1021/tx060123i. PMID 17040098. https://estudogeral.sib.uc.pt/bitstream/10316/12872/1/Synthesis%20and%20Cytotoxic%20Profile.pdf.

unibas.ch

edoc.unibas.ch

«Differential effects of MDMA and methylphenidate on social cognition». Journal of Psychopharmacology 28 (9): 847–56. September 2014. doi:10.1177/0269881114542454. PMID 25052243. http://edoc.unibas.ch/42235/1/20160316152928_56e96dc8bdaad.pdf.

unodc.org

World Drug Report 2018 (PDF). United Nations. Ιουνίου 2018. σελ. 7. ISBN 978-92-1-148304-8. Ανακτήθηκε στις 14 Ιουλίου 2018.
Mohan, J, επιμ. (Ιουνίου 2014). World Drug Report 2014 (PDF). Vienna, Austria: United Nations Office on Drugs and Crime. σελίδες 2, 3, 123–152. ISBN 978-92-1-056752-7. Ανακτήθηκε στις 1 Δεκεμβρίου 2014.
«Decision to place MDMA into Schedule I» (PDF). UNODC. Commission on Narcotic Drugs. 11 Φεβρουαρίου 1986. Ανακτήθηκε στις 9 Μαΐου 2015.
«Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory». United Nations Office on Drugs and Crime. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 2 Ιανουαρίου 2015.

vice.com

Bish, Joe (Aug 4, 2017). «Watch Out for Pentylone, the Horrible New MDMA Additive». Vice. https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive.

warwick.ac.uk

wrap.warwick.ac.uk

«The harmful health effects of recreational ecstasy: a systematic review of observational evidence». Health Technology Assessment 13 (6): iii–iv, ix–xii, 1–315. January 2009. doi:10.3310/hta13050. PMID 19195429. http://wrap.warwick.ac.uk/37399/1/WRAP_coversheet_Sutcliffe_Use_classical_novel.pdf.

washingtonpost.com

Wan, William (26 August 2017). «Ecstasy could be 'breakthrough' therapy for soldiers, others suffering from PTSD». Washington Post. Αρχειοθετήθηκε από το πρωτότυπο στις 29 August 2017. https://web.archive.org/web/20170829081013/https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.e5b3c1c4854a. Ανακτήθηκε στις 29 August 2017.
Vastag, Brian (3 June 2014). «Chemist Alexander Shulgin, popularizer of the drug Ecstasy, dies at 88». The Washington Post (WP Company LLC). https://www.washingtonpost.com/national/health-science/chemist-alexander-shulgin-popularizer-of-the-drug-ecstasy-dies-at-88/2014/06/03/19fd9580-eb34-11e3-b98c-72cef4a00499_story.html. Ανακτήθηκε στις 28 August 2015.

web.archive.org

«Can MDMA play a role in the treatment of substance abuse?». Current Drug Abuse Reviews 6 (1): 54–62. March 2013. doi:10.2174/18744737112059990005. PMID 23627786. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-08-03. https://web.archive.org/web/20200803194522/http://pdfs.semanticscholar.org/33fd/4f5decd405dee8d4f280a9158bfb16ae6e27.pdf. Ανακτήθηκε στις 2020-10-04. «Animal and human studies demonstrate moderate abuse liability for MDMA, and this effect may be of most concern to those treating substance abuse disorders.».
«Methylenedioxymethamphetamine (MDMA, ecstasy)». Drugs and Human Performance Fact Sheets. National Highway Traffic Safety Administration. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Μαΐου 2012.
«DrugFacts: MDMA (Ecstasy or Molly)». National Institute on Drug Abuse. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Δεκεμβρίου 2014. Ανακτήθηκε στις 2 Δεκεμβρίου 2014.
Anderson L, επιμ. (18 Μαΐου 2014). «MDMA». Drugs.com. Drugsite Trust. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Μαρτίου 2016. Ανακτήθηκε στις 30 Μαρτίου 2016.
«DrugFacts: MDMA (Ecstasy/Molly)». National Institute on Drug Abuse. Φεβρουαρίου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Μαρτίου 2016. Ανακτήθηκε στις 30 Μαρτίου 2016.
Patel V (2010). Mental and neurological public health a global perspective (1st έκδοση). San Diego, CA: Academic Press/Elsevier. σελ. 57. ISBN 978-0-12-381527-9. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Σεπτεμβρίου 2017.
«CBS proclaims 'cancer breakthrough' – doesn't explain what FDA means by that term». Health News Review. 13 May 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-12-08. https://web.archive.org/web/20201208215931/https://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/. Ανακτήθηκε στις 9 October 2017.
«Fact Sheet: Breakthrough Therapies». United States Food and Drug Administration. 10 Δεκεμβρίου 2014. Αρχειοθετήθηκε από το πρωτότυπο στις 9 Οκτωβρίου 2017. Ανακτήθηκε στις 9 Οκτωβρίου 2017. A breakthrough therapy is a drug:
Πρότυπο:Bullintended alone or in combination with one or more other drugs to treat a serious or life-threatening disease or condition and
Πρότυπο:Bullpreliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.
Wan, William (26 August 2017). «Ecstasy could be 'breakthrough' therapy for soldiers, others suffering from PTSD». Washington Post. Αρχειοθετήθηκε από το πρωτότυπο στις 29 August 2017. https://web.archive.org/web/20170829081013/https://www.washingtonpost.com/national/health-science/ecstasy-could-be-breakthrough-therapy-for-soldiers-others-suffering-from-ptsd/2017/08/26/009314ca-842f-11e7-b359-15a3617c767b_story.html?utm_term=.e5b3c1c4854a. Ανακτήθηκε στις 29 August 2017.
MDMA and Religion Αρχειοθετήθηκε 2013-04-24 στο Wayback Machine.. CSP. Retrieved on 11 June 2011.
Nov 2005 DEA Microgram newsletter, p. 166 Αρχειοθετήθηκε 18 October 2012 στο Wayback Machine.. Usdoj.gov (11 November 2005). Retrieved on 12 August 2013.
Firma E. Merck in Darmstadt (16 Μαΐου 1914). «German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten». Kaiserliches Patentamt. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 12 Απριλίου 2009.
Firma E. Merck in Darmstadt (15 Οκτωβρίου 1914). «German Patent 279194: Verfahren zur Darstellung von Hydrastinin Derivaten». Kaiserliches Patentamt. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
«Alexander 'Sasha' Shulgin». Alexander Shulgin Research Institute. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Δεκεμβρίου 2014. Ανακτήθηκε στις 8 Ιανουαρίου 2015.
Jennings, Peter (1 April 2004). «Ecstasy Rising». Primetime Thursday (ABC News) (Special edition). Αρχειοθετήθηκε από το πρωτότυπο στις 27 May 2015. https://web.archive.org/web/20150527163756/http://www.thedocumentarygroup.com/PJP/Transcripts%20Files/Script_Ecstasy.doc.
Savlov, Marc (12 June 2000). «Countdown to Ecstasy: A New Drug for a New Millennium». The Austin Chronicle (Weekly Wire). Αρχειοθετήθηκε από το πρωτότυπο στις 2016-01-21. https://web.archive.org/web/20160121022839/http://weeklywire.com/ww/06-12-00/austin_music_feature.html. Ανακτήθηκε στις 6 August 2015.
«Mephedrone (4-Methylmethcathinone) appearing in "Ecstasy" in the Netherlands». 19 September 2010. Αρχειοθετήθηκε από το πρωτότυπο στις 2012-11-05. https://web.archive.org/web/20121105125943/http://scientopia.org/blogs/drugmonkey/2010/09/19/mephedrone-4-methylmethcathinone-appearing-in-ecstasy-in-the-netherlands/. Ανακτήθηκε στις 31 December 2012.
«Committee: the current system of the Opium Act does not have to be changed». government.nl. 24 Ιουνίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Απριλίου 2012. Ανακτήθηκε στις 29 Αυγούστου 2012.
«Schedule I». Controlled Drugs and Substances Act. Isomer Design. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013. Ανακτήθηκε στις 9 Δεκεμβρίου 2013.
«Definitions and interpretations». Controlled Drugs and Substances Act. Isomer Design. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013. Ανακτήθηκε στις 9 Δεκεμβρίου 2013.
European Monitoring Centre for Drugs and Drug Addiction (2008). Annual report: the state of the drugs problem in Europe (PDF). Luxembourg: Office for Official Publications of the European Communities. σελ. 49. ISBN 978-92-9168-324-6. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 25 Απριλίου 2013. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
«European Drug Report 2014, page 26» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 7 Σεπτεμβρίου 2014. Ανακτήθηκε στις 4 Οκτωβρίου 2020.
«Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory». United Nations Office on Drugs and Crime. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 2 Ιανουαρίου 2015.
Drugtext – 10 years of ecstasy and other party drug use in Australia: What have we done and what is there left to do?. Drugtext.org. Retrieved on 11 June 2011. Αρχειοθετήθηκε 9 February 2012 στο Wayback Machine.
Lattin, Don (19 Μαρτίου 2015). «Patients in ecstasy clinical trial find drug beneficial». San Francisco Chronicle. Hearst Corporation. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Απριλίου 2016. Ανακτήθηκε στις 28 Απριλίου 2016.
Philipps, Dave (29 November 2016). «F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients». The New York Times. The New York Times Company. Αρχειοθετήθηκε από το πρωτότυπο στις 6 January 2017. https://web.archive.org/web/20170106084750/http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html. Ανακτήθηκε στις 1 December 2016.

weeklywire.com

Savlov, Marc (12 June 2000). «Countdown to Ecstasy: A New Drug for a New Millennium». The Austin Chronicle (Weekly Wire). Αρχειοθετήθηκε από το πρωτότυπο στις 2016-01-21. https://web.archive.org/web/20160121022839/http://weeklywire.com/ww/06-12-00/austin_music_feature.html. Ανακτήθηκε στις 6 August 2015.

who.int

whqlibdoc.who.int

WHO Expert Committee on Drug Dependence: Twenty-second Report (PDF). Geneva: World Health Organization. 1985. σελίδες 24–25. ISBN 978-9241207294. Ανακτήθηκε στις 29 Αυγούστου 2012.

worldcat.org

Hysek, CM; Schmid, Y; Rickli, A; Simmler, LD; Donzelli, M; Grouzmann, E; Liechti, ME (August 2012). «Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans». British Journal of Pharmacology 166 (8): 2277–2288. doi:10.1111/j.1476-5381.2012.01936.x. ISSN 0007-1188. PMID 22404145. PMC 3448893. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448893/.

zenodo.org

«Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites». European Journal of Pharmacology 149 (1–2): 159–63. April 1988. doi:10.1016/0014-2999(88)90056-8. PMID 2899513. https://zenodo.org/record/1253866.